David Verhoeven

Title: The Innovative Contributions of David Verhoeven

Introduction

David Verhoeven is a notable inventor based in Ames, Iowa. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 2 patents, his work focuses on creating effective solutions for influenza viruses.

Latest Patents

One of Verhoeven's latest patents is a Universal Mammalian Influenza Vaccine. This invention provides vaccine or immunogenic compositions that comprise novel antigens derived from the equine strain of influenza H3N8. The proteins and specific immunogenic domains included in this vaccine are effective as primary universal influenza antigens. The disclosed vaccines or immunogenic compositions are highly effective in inducing HA specific antibodies that are reactive to different influenza viruses. They also promote mucosal and systemic immune responses, offering cross-protection regardless of influenza virus subtypes. In some embodiments, the vaccine is cross-protective against two or more subtypes of influenza, with or without the use of an adjuvant.

Career Highlights

David Verhoeven is affiliated with the Iowa State University Research Foundation, Inc. His work at this institution has allowed him to focus on innovative research and development in the field of vaccines. His contributions have the potential to impact public health significantly.

Collaborations

Verhoeven collaborates with talented individuals such as Jessie Dorothy Trujillo and Brett Sponseller. These partnerships enhance the research and development process, leading to more effective solutions in the field of immunology.

Conclusion

David Verhoeven's innovative work in vaccine development showcases his commitment to advancing medical science. His contributions, particularly in creating a universal influenza vaccine, highlight the importance of research in combating viral infections.